VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
UNM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
UNMUnum Group
$76.39$12.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksUNMFinancials

Unum Group (UNM) Income Statement

30Y historyFree accessUpdated daily

Revenue growth has decelerated toward low single digits and underwriting results have swung widely, with the loss ratio ranging from 3.0% to 81.4% and the combined ratio reaching 119.4% in Q3 2026, suggesting claims volatility is the dominant driver of reported earnings.

Income StatementBalance SheetCash FlowRatios

UNM Income Statement

Annual statement

UNM Income Statement

Unum Group (UNM) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue12.44B13.05B12.79B12.31B11.88B11.84B13.15B11.99B11.6B11.29B11.05B10.73B10.52B10.37B10.52B10.28B10.19B10.09B9.98B10.52B10.54B10.44B10.46B9.82B9.08B9B9.07B9.33B8.52B7.68B4.07B
Revenue Growth %-4.21%2.07%3.91%3.65%0.32%-9.96%9.63%3.4%2.76%2.18%2.94%1.96%1.5%-1.4%2.31%0.83%1.01%1.09%-5.11%-0.15%0.94%-0.26%6.58%8.08%0.91%-0.76%-2.77%9.51%10.97%88.55%-1.24%
Medical Costs & Claims7.97B8.07B8.05B8.28B7.95B8.52B10.06B8.57B9.03B8.02B7.87B7.69B8.16B7.46B7.55B8.01B7.16B6.89B8.07B8.39B7.63B8.07B8.24B8.99B7.14B6.73B6.92B8.07B6.53B5.39B2.05B
Medical Cost Ratio %64.11%61.78%62.91%67.24%66.91%71.98%76.52%71.46%77.82%71.02%71.24%71.68%77.56%71.92%71.81%77.95%70.25%68.23%80.85%79.71%72.39%77.28%78.76%91.59%78.65%74.73%76.29%86.52%76.66%70.25%50.3%
Gross Profit4.46B4.99B4.74B4.03B3.93B3.32B3.09B3.42B2.57B3.27B3.18B3.04B2.36B2.91B2.96B2.27B3.03B3.21B1.91B2.13B2.91B2.37B2.22B826M1.94B2.27B2.15B1.26B1.99B2.28B2.02B
Gross Margin %35.89%38.22%37.09%32.76%33.09%28.02%23.48%28.54%22.18%28.98%28.76%28.32%22.44%28.08%28.19%22.05%29.75%31.77%19.15%20.29%27.61%22.72%21.24%8.41%21.35%25.27%23.71%13.48%23.34%29.75%49.7%
Gross Profit Growth %-5.16%17.65%2.61%18.46%7.47%-9.8%33.05%-21.37%2.95%4.53%28.71%-18.88%-1.8%30.82%-25.28%-5.39%67.69%-10.43%-26.62%22.67%6.68%169.07%-57.41%-14.74%5.76%70.98%-36.75%-12.92%12.86%-33.1%
Operating Expenses4.11B4.06B2.49B2.39B2.18B2.06B2.12B2.04B1.94B1.87B1.83B1.8B1.82B1.69B1.72B1.93B1.71B1.91B1.09B1.14B2.44B1.66B2.48B1.28B1.36B1.52B1.33B1.42B1.07B801.1M-995.9M
OpEx / Revenue %33.03%31.07%19.49%19.44%18.36%17.37%16.15%17.01%16.76%16.54%16.56%16.79%17.29%16.31%16.31%18.81%16.81%18.96%10.9%10.81%23.19%15.92%23.72%13.02%15.03%16.89%14.66%15.26%12.54%10.43%-24.46%
Depreciation & Amortization147.7M123M116.1M108.8M110.5M119.8M113.6M110.1M101.4M103.4M101.7M99.5M87.9M84.8M84.3M81.1M75.4M74.5M68.8M66.2M80.5M87.8M80.5M761.8M510.3M573M594.9M653.7M492M138.9M75.1M
Combined Ratio %97.14%92.85%82.4%86.68%85.26%89.35%92.67%88.48%94.59%87.56%87.8%88.46%94.85%88.23%88.12%96.76%87.05%87.19%91.75%90.52%95.58%93.2%102.48%104.61%93.68%91.63%90.95%101.77%89.2%80.69%25.84%
Operating Income355.2M933.5M2.25B1.64B1.75B1.26B964M1.38B627.8M1.4B1.35B1.24B542M1.22B1.25B333.3M1.32B1.29B824M997.2M465.4M709.6M-259.5M-452.4M574.3M753.8M821.2M-165.5M920.2M1.48B3.02B
Operating Margin %2.86%7.15%17.6%13.32%14.74%10.65%7.33%11.52%5.41%12.44%12.2%11.54%5.15%11.77%11.88%3.24%12.95%12.81%8.25%9.48%4.42%6.8%-2.48%-4.61%6.32%8.37%9.05%-1.77%10.8%19.31%74.16%
Operating Income Growth %--58.54%37.27%-6.28%38.82%30.77%-30.25%120.15%-55.28%4.18%8.83%128.47%-55.57%-2.36%274.89%-74.75%2.14%56.83%-17.37%114.27%-34.41%373.45%42.64%-178.77%-23.81%-8.21%596.19%-117.99%-37.94%-50.89%9.39%
EBITDA502.9M1.06B2.37B1.75B1.86B1.38B1.08B1.49B729.2M1.51B1.45B1.34B629.9M1.3B1.33B414.4M1.4B1.37B892.8M1.06B545.9M797.4M-179M309.4M1.08B1.33B1.42B488.2M1.41B1.62B3.09B
EBITDA Margin %4.04%8.09%18.51%14.21%15.67%11.66%8.2%12.44%6.29%13.36%13.12%12.47%5.99%12.58%12.68%4.03%13.69%13.54%8.94%10.11%5.18%7.64%-1.71%3.15%11.94%14.74%15.61%5.23%16.58%21.12%76%
Interest Expense213M208.8M201.1M194.8M188.5M185M188.2M177.4M167.3M159.9M166M152.8M167.5M149.4M145.4M143.3M141.8M125.4M156.7M241.9M191.8M208M207.1M187.2M162.4M169.6M181.8M137.8M119.9M84.9M241.3M
Non-Operating Income-159M-208.8M-201.1M-194.8M-188.5M-185M-188.2M-177.4M-167.3M-159.9M-166M-152.8M-167.5M-149.4M-145.4M-143.3M-141.8M-125.4M-156.7M-241.9M-191.8M-208M-207.1M-204.4M-162.4M-169.6M-181.8M-137.8M-119.9M1.4B2.78B
Pretax Income301.2M933.5M2.25B1.64B1.75B1.26B964M1.38B627.8M1.4B1.35B1.24B542M1.22B1.25B333.3M1.32B1.29B824M997.2M465.4M709.6M-259.5M-452.4M574.3M753.8M821.2M-165.5M920.2M916.7M341.6M
Pretax Margin %2.42%7.15%17.6%13.32%14.74%10.65%7.33%11.52%5.41%12.44%12.2%11.54%5.15%11.77%11.88%3.24%12.95%12.81%8.25%9.48%4.42%6.8%-2.48%-4.61%6.32%8.37%9.05%-1.77%10.8%11.94%8.39%
Income Tax57.9M195M472.2M356.3M342.8M279.6M171M281.8M104.4M409.8M416.3M371.2M139.9M373M355.1M49.1M441.2M439.7M270.8M324.8M61.8M196M-67.3M-177.9M196.3M216.1M284M17.4M302.8M299.1M103.6M
Effective Tax Rate %19.22%20.89%20.97%21.72%19.59%22.18%17.74%20.39%16.63%29.19%30.89%29.98%25.81%30.57%28.42%14.73%33.43%34.02%32.86%32.57%13.28%27.62%25.93%39.32%34.18%28.67%34.58%-10.51%32.91%32.63%30.33%
Net Income243.3M738.5M1.78B1.28B1.41B981M793M1.1B523.4M994.2M931.4M867.1M402.1M847M894.4M284.2M878.7M852.6M553.2M679.3M411M513.6M-253M-386.4M401.2M541.2M538.9M-182.9M617.4M617.6M238M
Net Margin %1.96%5.66%13.91%10.43%11.85%8.29%6.03%9.17%4.51%8.81%8.43%8.08%3.82%8.17%8.51%2.77%8.62%8.45%5.54%6.46%3.9%4.92%-2.42%-3.94%4.42%6.01%5.94%-1.96%7.25%8.04%5.85%
Net Income Growth %-73.35%-58.49%38.58%-8.77%43.45%23.71%-27.93%110.22%-47.35%6.74%7.42%115.64%-52.53%-5.3%214.71%-67.66%3.06%54.12%-18.56%65.28%-19.98%303%34.52%-196.31%-25.87%0.43%394.64%-129.62%-0.03%159.5%-15.33%
EPS (Diluted)1.534.289.466.506.964.023.895.242.384.373.953.501.573.233.170.942.692.571.621.911.231.64-0.86-1.481.662.212.22-0.772.542.571.61
EPS Growth %-72.51%-54.76%45.54%-6.61%73.13%3.34%-25.76%120.17%-45.54%10.63%12.86%122.93%-51.39%1.89%237.23%-65.06%4.67%58.64%-15.18%55.28%-25%290.7%41.89%-189.16%-24.89%-0.45%388.31%-130.31%-1.17%59.63%-16.15%
EPS (Basic)-4.289.496.537.014.043.895.252.384.393.963.511.573.243.180.942.702.571.621.921.271.74-0.86-1.481.662.242.24-0.772.602.621.63
Diluted Shares Outstanding158.61M172.92M188.07M197.6M202.11M204.85M203.76M209.85M220.1M227.3M236M247.9M256.11M265.9M281.76M303.57M327.22M332.14M341.56M355.78M334.15M313.17M294.19M261.33M243.48M244.89M242.75M237.53M141.24M143.46M147.83M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Underwriting volatility from claims

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Top-Line Growth Decelerating Toward Low Single Digits

Based on the reported quarterly figures, Unum's revenue growth slowed to 2.1% year-over-year, with the most recent quarter showing a sharp 24.1% decline, suggesting premium momentum has weakened materially from the mid-single-digit pace seen through 2025.

The reported figures show revenue oscillating between roughly $3.1B and $3.4B across the ten quarters, which points to a largely flat premium base rather than a compounding franchise. The steep Q3 2026 contraction may reflect timing effects or a genuine slowdown in insured payroll, and the data alone cannot separate the two. Investors should monitor whether the deceleration persists, since sustained low growth would constrain the premium base that underpins long-tail disability reserves.

Underwriting Results Swing on Claims Volatility

As reported in the quarterly income statements, Unum's loss ratio ranged from 3.0% to 81.4%, and the combined ratio exceeded 100% in Q3 2026, indicating underwriting losses in that period that were not offset by investment income.

The wide dispersion in loss ratios, particularly the anomalously low 3.0% in Q3 2024 alongside 78% to 81% readings in other periods, suggests reserve adjustments or non-recurring items are distorting quarterly comparisons. A combined ratio above 100% means underwriting alone lost money, leaving profitability dependent on investment income. The pattern warrants further investigation into whether claims costs reflect morbidity trends or actuarial reassessments.

Reserve Adequacy Obscured by Quarterly Noise

Based on reported figures, the sharp swing between a 3.0% loss ratio in Q3 2024 and above 78% in subsequent periods suggests reserve development may be materially affecting reported earnings and warrants close scrutiny.

Given the Closed Block's legacy long-term care exposure, prior-year reserve releases could flatter current earnings while later strengthening reverses the benefit. The reported data does not isolate reserve development, so its contribution cannot be quantified from these figures. Analysts should adjust for any reserve strengthening or unlocking events before extrapolating recent profitability.

Investment Income Contribution Not Disclosed

The supplied income statement data does not report investment income or investment yield, so the portfolio's contribution to total earnings cannot be assessed from the provided figures.

Because net income remains positive in most quarters despite combined ratios near or above 100%, investment returns likely play a meaningful role, though this is inference rather than disclosed fact. The absence of reported yield data means the spread between portfolio returns and liability costs cannot be verified. Investors should consult the full filings to evaluate how interest rate sensitivity affects the earnings base.

Quarterly Earnings Miss Challenges Stability Thesis

Based on Unum's reported Q2 2026 results, EPS of $1.61 and a Q3 2026 net loss of $419.7M, with no forward guidance provided, challenge the view that earnings have stabilized.

The most recent quarter's swing to a net loss and a combined ratio of 119.4% suggests underwriting pressure that may not be transitory, despite management's reported emphasis on steady premium growth. The lack of forward guidance introduces additional uncertainty about the H2 2026 trajectory. Investors should weigh whether these results reflect one-off items or a broader deterioration in claims experience.

UNM — Frequently Asked Questions

Quick answers to the most common questions about buying UNM stock.

What was Unum Group's (UNM) revenue in 2025?

For fiscal year 2025, Unum Group (UNM) reported total revenue of $13.05B. This represents a 220.6% increase compared to $4.07B in 1996.

Is Unum Group (UNM) profitable?

Unum Group (UNM) is profitable, generating $738.5M in net income for the fiscal year ending 2025 with a net profit margin of 5.7%.

What is Unum Group's operating profit margin?

Unum Group (UNM) reported an operating income of $933.5M, resulting in an operating profit margin of 7.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Unum Group's gross profit and gross margin?

Unum Group (UNM) generated $4.99B in gross profit for the year, representing a gross profit margin of 38.2%. This demonstrates the company's core pricing power and production efficiency.